Research Insight
Research Insight
Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohns Disease
Takeda Pharmaceutical Company Limited announced results from the phase 3 VISIBLE 2 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC) formulation...
Research Insight
Imminence of New Gonorrhea Therapeutic Drugs is Evident as the Bacteria Grow Super Resistant to Antibiotics
According to a new study, the gonorrhea therapeutics market will reach US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over 2018....
Research Insight
Road to Cell Death More Clearly Identified for Parkinson’s Disease
A pathway toward cellular death named for Thanatos identified by researchers as a key driver of nerve cell degradation in Parkinson’s disease
Dopamine neurons are the...
Research Insight
Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma
A multi-institutional research team, led by investigators at Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, has identified specific states of...
Research Insight
UCLA researchers develop mechanism for characterizing function of rare tumor cells
Scientists have long known that circulating tumor cells, rare cancer cells that are released into the bloodstream, have the potential to provide vital information about...
Research Insight
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
VolitionRx Limited announced preliminary data from a prospective, multi-centered Proof of Concept Study of 84 men into the utility of Volition's Nu.Q™ assays to diagnose...
Research Insight
Precision Medicine Researchers Identify New Alzheimer’s Genes
Researchers from Boston University School of Medicine, in collaboration with scientists from the Alzheimer’s Disease Sequencing Project (ADSP), have discovered new genes that could contribute...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.